Table 3
Prevalence of Abs to SS-A/Ro and SS-B/La in patients with SS with ACA and those without ACA
ACA
Abs to SS-A/Ro
Abs to SS-B/La
Seropositive group
6/28 (21.4%)
0/28 (0%)
Seronegative group
98/174 (56.3%)
23/174 (13.2%)
Statistical analysis
p=0.0013
p=0.0495